| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Glenmark Pharmaceuticals Ltd soars 1.8%, rises for third straight session | 2 | capitalmarket.com | ||
| 21.08. | Glenmark Pharma's US arm launches Calcium Gluconate injection in various formats | 2 | capitalmarket.com | ||
| 21.08. | Glenmark Pharmaceuticals among 5 stocks showing bullish RSI upswing | 2 | Times of India | ||
| 20.08. | Glenmark Pharma gets USFDA nod for Fluticasone Propionate Nasal Spray | 2 | capitalmarket.com | ||
| 03.08. | Glenmark Q1 FY27 slides: 23% revenue growth, innovation pipeline expands | 3 | Investing.com | ||
| 15.07. | Glenmark Pharmaceuticals Ltd soars 0.08%, up for fifth straight session | 3 | capitalmarket.com | ||
| 06.07. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 2 | capitalmarket.com | ||
| 06.07. | Glenmark Pharma gains as US arm launches generic Olanzapine injection | 2 | capitalmarket.com | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 17.06. | Glenmark Pharma arm launches generic Methylene Blue Injection in US market | 3 | capitalmarket.com | ||
| 11.06. | Glenmark Pharmaceuticals launches Winlevi across key European markets | 2 | capitalmarket.com | ||
| 11.06. | Cosmo Pharmaceuticals N.V.: Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark | 791 | Newsfile | Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) ("Cosmo") is pleased to make known that its commercial partner Glenmark Specialty S.A (GSSA), a wholly-owned... ► Artikel lesen | |
| 10.06. | Stock Alert: KRN Heat, Patanjali Foods, Bharti Airtel, Dixon Tech, Glenmark Pharma, Bharti Hexacom | 3 | capitalmarket.com | ||
| 05.06. | Glenmark Pharma launches generic Lacosamide injection in US | 2 | capitalmarket.com | ||
| 02.06. | Klage gegen Glenmark: Lieferengpässe: Kein Schadenersatz für DAK | 4 | APOTHEKE ADHOC | ||
| 01.06. | Stocks to Watch Today (June 01, 2026): IndiGo, Glenmark Pharma, IREDA, NMDC, Jubilant Pharmova, Cyient and more | 2 | ZEE Business | ||
| 01.06. | Stock Alert: RPP Infra Projects, Indigo, NMDC, GRM Overseas, Glenmark Pharma, NOCIL | 2 | capitalmarket.com | ||
| 30.05. | Glenmark Pharma posts robust Q4 performance | 3 | capitalmarket.com | ||
| 20.05. | IGI, Inc.: Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors | 637 | GlobeNewswire (Europe) | Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) cells
IGI's clinically validated BEAT platform enabled... ► Artikel lesen | |
| 18.05. | Glenmark Launches Vancomycin Injection In US, Targets Rs 37.9 Million Market | 2 | The Free Press Journal | ||
| 12.05. | Glenmark Pharmaceuticals Ltd slips for fifth straight session | 2 | capitalmarket.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 1,760 | +0,74 % | SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE SIX MONTHS ENDED 30 JUNE 2026 | ||
| CSPC PHARMA | 1,090 | +1,45 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2069 INJECTION FOR WEIGHT MANAGEMENT IN ADULT PATIENTS WITH OVERWEIGHT OR ... | ||
| WUXI BIOLOGICS | 5,590 | +0,72 % | WuXi Biologics Reports Strong Profitable Growth in H1 2026 | Revenue of RMB 11.8 billion grew 18.4% YoY (23.4% YoY in USD)
IFRS gross profit margin expanded to 46.2% (+350 bps YoY) and adjusted gross profit margin expanded... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,841 | +1,57 % | Fosun Pharma Announces 2026 Interim Results | Globalization Accelerates Value Realization of Innovative Drugs
SHANGHAI, Aug. 25, 2026 /PRNewswire/ -- On August 25, Fosun Pharma ("the Company", stock code: 600196.SH... ► Artikel lesen | |
| GEDEON RICHTER | 36,340 | 0,00 % | Gedeon Richter Plc.: Transactions with Treasury Shares | ||
| DR REDDYS | 10,400 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ASPEN PHARMACARE | 8,150 | -3,55 % | ASPEN PHARMACARE HOLDINGS LIMITED - Business update and trading statement for the year ended 30 June 2026 | ||
| SHANGHAI PHARMACEUTICALS | 1,290 | +2,38 % | Shanghai Pharmaceuticals Holding Co Ltd Reports Fall In H1 Profit | ||
| LUYE PHARMA | 0,230 | +0,88 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT MRNA VACCINE LY01620 FOR THE TREATMENT OF CERVICAL PRECANCEROUS LESIONS AND HPV-RELATED TUMORS TO ENTER INTO ... | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,085 | -5,06 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE | ||
| HANSOH PHARMACEUTICAL | 3,975 | -1,71 % | G Sachs Raises HANSOH PHARMA TP to HKD52.7, Lifts Earnings Forecasts as 1H Results Beat | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,486 | -3,76 % | CLSA Cuts CHINARES PHARMA TP to HKD6.5, Lowers Revenue and Profit Forecasts | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,915 | -2,14 % | China Shineway Pharmaceutical Group Limited Reports Drop In H1 Profit | ||
| KALBE FARMA | 0,031 | 0,00 % | Dividendenbekanntmachungen (04.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-LIVING SMART CITY SERVICES CO LTD CNE100002RY5 0,0688 HKD 0,0075 EUR ADESSO SE DE000A0Z23Q5 - 0,78 EUR AGEAS SA/NV ADR US00844W2089 2... ► Artikel lesen | |
| BAYER | 48,670 | +0,39 % | Aus für die Chemie-Keule: Bayer-Partner MustGrow Biologics mit Fortschritten - hat sich Bioceres verhoben? | Erstellt und veröffentlicht im Auftrag von MustGrow Biologics Corp. Die Landwirtschaft steht vor einer Zäsur. Strenge Umweltauflagen verbannen chemische Pflanzenschutzmittel zunehmend von den Feldern.... ► Artikel lesen |